Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) Bernard Escudier et al.   ANNALS OF ONCOLOGY

Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

(2018) Roberto Iacovelli et al.   Clinical Genitourinary Cancer

The effect of age on cancer specific mortality in patients with small renal masses: A population-based analysis

(2018) Marco Bandini et al.   CUAJ-Canadian Urological Association Journal

Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

(2018) Gladell P. Paner et al.   EUROPEAN UROLOGY

Epidemiology of Renal Cell Carcinoma

(2018) Umberto Capitanio et al.   EUROPEAN UROLOGY

Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy

(2017) Marco Bandini et al.   WORLD JOURNAL OF UROLOGY

Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

(2016) Tomohiro F. Nishijima et al.   CANCER TREATMENT REVIEWS

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

(2016) Naomi B Haas et al.   LANCET

Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)

(2014) Rodolfo Passalacqua et al.   JOURNAL OF IMMUNOTHERAPY

Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis

(2012) Yong Hyun Park et al.   BJU INTERNATIONAL

The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma

(2011) Min-Han Tan et al.   CANCER

TNM Staging for Renal Cell Carcinoma: Time for a New Method

(2010) Scott Eggener   EUROPEAN UROLOGY

The ‘Stage, Size, Grade and Necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma

(2008) Vincenzo Ficarra et al.   BJU INTERNATIONAL